Novel dual BET and PLK1 inhibitor WNY0824 exerts potent anti-tumor effects in CRPC by inhibiting transcription factor function and inducing mitotic abnormality

2020 ◽  
pp. molcanther.0578.2019
Author(s):  
Ying Xu ◽  
Qianqian Wang ◽  
Kunjie Xiao ◽  
Zhihao Liu ◽  
Lifeng Zhao ◽  
...  
2011 ◽  
Vol 32 (10) ◽  
pp. 1144-1152 ◽  
Author(s):  
Daniel Kelberman ◽  
Lily Islam ◽  
Susan E. Holder ◽  
Thomas S. Jacques ◽  
Patrick Calvas ◽  
...  

2005 ◽  
Vol 2005 (Spring) ◽  
Author(s):  
Christian Behrends ◽  
Gregor Schaffar ◽  
Peter Breuer ◽  
Raina Boteva ◽  
Nikolay Tzvetkov ◽  
...  

2008 ◽  
Vol 105 (6) ◽  
pp. 2232-2237 ◽  
Author(s):  
B. Al-Sady ◽  
E. A. Kikis ◽  
E. Monte ◽  
P. H. Quail

2013 ◽  
Vol 2013 ◽  
pp. 1-9 ◽  
Author(s):  
Richard L. Eckert ◽  
Gautam Adhikary ◽  
Christina A. Young ◽  
Ralph Jans ◽  
James F. Crish ◽  
...  

AP1 (jun/fos) transcription factors (c-jun, junB, junD, c-fos, FosB, Fra-1, and Fra-2) are key regulators of epidermal keratinocyte survival and differentiation and important drivers of cancer development. Understanding the role of these factors in epidermis is complicated by the fact that each protein is expressed, at different levels, in multiple cells layers in differentiating epidermis, and because AP1 transcription factors regulate competing processes (i.e., proliferation, apoptosis, and differentiation). Variousin vivogenetic approaches have been used to study these proteins including targeted and conditional knockdown, overexpression, and expression of dominant-negative inactivating AP1 transcription factors in epidermis. Taken together, these studies suggest that individual AP1 transcription factors have different functions in the epidermis and in cancer development and that altering AP1 transcription factor function in the basal versus suprabasal layers differentially influences the epidermal differentiation response and disease and cancer development.


Sign in / Sign up

Export Citation Format

Share Document